Real-time enrollment status for this bladder cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT02138734 |
| Recruiting Status | Recruiting |
| Condition | Bladder Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 596 participants |
| Active Locations | 51 sites in the US |
| Sponsor | ImmunityBio, Inc. |
| Last Updated on CT.gov | October 16, 2025 (Oct 16, 2025) |
As of March 2, 2026: Clinical trial NCT02138734 is currently recruiting participants. This clinical trial study for bladder cancer is actively seeking new participants at 51 locations across the United States. The study is sponsored by ImmunityBio, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02138734 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 51 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02138734 was last updated Oct 16, 2025 (October 16, 2025). HelloStudys verifies this status automatically.